Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 Trial

Xu Liu, Ling Guo, Fang Yun Xie, Wei Han Hu, Ming Yuan Chen, Qing Mei He, Zhi Min Xu, Chu Qing Zhang, Ying Lin Peng, Ling Long Tang, Yan Ping Mao, Rui Sun, Ji Bin Li, Athanassios Argiris, Edwin P. Hui, Ying Sun, Jun Ma

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 Trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Nursing and Health Professions

Neuroscience